BioForward supported the following initiatives:
National Advocacy Update
Medical Device User Fee Amendments (MDUFA):
The Senate approved H.R. 2430, the FDA Reauthorization Act of 2017, as passed by the House. The measure was passed by a vote of 94 to 1. The bill will now be sent to the President who is expected to sign it. This important package includes several key positive provisions for the medtech industry. https://www.advamed.org/newsroom/press-releases/advamed-applauds-senate-vote-mdufa-reauthorization
Food and Drug Reauthorization Act (FDARA) & Prescription Drug User Fee Program (PDUFA):
On August 3rd, the Senate passed the Food and Drug Reauthorization Act (FDARA), which includes the Prescription Drug User Fee Program. Next, it will go to the President to be signed into law. The user fee program reauthorization package passed by the Senate today is an important victory for patients and for the next generation of medical innovation. This legislation will advance patient involvement in drug development and bring patient perspectives more clearly to bear on regulatory decisions. It also ensures that the FDA continues to have the resources necessary to carry out its critical human drug review programs, and takes steps to modernize and improve the clinical trial process, which remains the most time-consuming, complex and expensive stage of drug development. http://action.bio.org/f0pQtVh
Medicare Part B:
Signed onto a letter to Secretary Price to protect Medicare Part B for reimbursing providers for drugs and biologics administered by physicians.
Drug pricing continues to be a topic of discussion and debate. BIO has developed a web site to provide more transparency to this issue through the following web site: http://www.drugcostfacts.org/
State Advocacy Update
Foxconn Investment in Wisconsin:
After a recent announcement of Foxconn Technology Group investing in a high-tech manufacturing plant in Southeast Wisconsin, a public hearing was held on August 3rd at the Wisconsin State Capital.
Lisa Johnson, CEO of BioForward, spoke on behalf of Foxconn promoting the opportunities it can provide to the biohealth industry in Wisconsin.
Interested in More Legislative Insight?
Hear from national and local government relations leaders on the status of healthcare and biohealth legislation at the Wisconsin Biohealth Summit panel: Looking Forward: The Impact of Future Healthcare Reform on the Biohealth Industry. Learn more and register today: http://www.bioforward.org/wisconsin-biohealth-summit/